Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes.

When these 2 mutations in AS and MTF genes were separately analyzed, it still showed a statistical trend toward higher frequency of these mutations in the failure/progression group ( P = .07 and .05, respectively).

also in 803 other papers